NCT05402449View on ClinicalTrials.gov

To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 14, 2022

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
OTHER

Placebo

Same Additives to Probiotic group but replace probiotics with Corn starch and Maltodextrin.

DIETARY_SUPPLEMENT

Probiotics

Multi-strain probiotic supplement includes Lactobacillus reuteri GMNL-263 (heat-killed) and GMNL-89 (alive) and Lactobacillus rhamnosus GMNL-74 ( alive).

Trial Locations (1)

Unknown

Fu Jen Catholic University Hospital, New Taipei City

All Listed Sponsors
collaborator

Fu Jen Catholic University Hospital

OTHER

lead

GenMont Biotech Incorporation

INDUSTRY